SDC’s Ahmed: Washington Rejects Any Turkish Attack Inside Syrian Territory

Head of SDC Ilham Ahmed (Asharq Al-Awsat)
Head of SDC Ilham Ahmed (Asharq Al-Awsat)
TT

SDC’s Ahmed: Washington Rejects Any Turkish Attack Inside Syrian Territory

Head of SDC Ilham Ahmed (Asharq Al-Awsat)
Head of SDC Ilham Ahmed (Asharq Al-Awsat)

Turkish President Recep Tayyip Erdogan is once again threatening to launch a new cross-border military operation in Syria against the remaining areas of the Syrian Democratic Forces (SDF) and the Kurdish People's Protection Units (YPG).

US armed forces, Russian forces and forces loyal to Syrian President Bashar al-Assad are deployed side by side in the areas run by the SDF and YPG.

In an interview with Asharq Al-Awsat, Ilham Ahmed, the executive chief of the Kurdish Syrian Democratic Council (SDC), discussed the anticipated Turkish operation, the positions of major countries and the Damascus government, and the Astana track meetings.

The SDC is the political wing of the SDF, which is backed by a US-led international coalition.

When asked about a potential Turkish military operation at a time the Syria talks, sponsored by Russia, Turkey and Iran, are taking place in the Kazakh capital, Ahmed ruled out Ankara getting the green light to attack SDF territory in Syria.

“All the meetings of the Astana process did not bring the desired results for Syrians,” said Ahmed.

“We do not hope that Turkey will be given the green light to carry out its aggressive campaign against the Syrians in the Autonomous Administration (Rojava) areas,” she added.

“Russia, more than anyone else, knows that Turkey is trying to obtain approval to carry out its operation,” explained Ahmed, adding that Moscow is well aware that areas occupied by Turkey in Syria are turning into hotbeds of terrorism that fuel the Syrian crisis and civil war.

Regarding foreign opposition to the expected Turkish military operation, Ahmed noted that US diplomats had relayed Washington’s rejection of any such action.

“They told us that they are against any further military operation of Turkey inside Syrian territory,” said Ahmed.

“We hope that there will be more deterrent stances from Washington to the Turkish actions that endanger the security and stability of the entire region,” she added.

As for Russia deploying forces, Ahmed said: “So far, Russian forces have not deployed more soldiers on the ground. They have control checkpoints on the border with Turkey, and they are running ground and air patrols inside Syrian territory.”

“While we are seeking full coordination with Russian forces to repel potential Turkish attacks, Moscow is required to take additional measures to protect the borders,” affirmed Ahmed.

“Turkey announced to the world that its map includes the entire border strip with a depth of 30 km, so it does not matter if it is currently promoting the names of some areas,” said Ahmed about Erdogan’s threat against Tal Rifaat and Manbij in the northern countryside of Aleppo governorate.

Ahmed moved on to explain that Turkey is adopting a nibble-by-piece policy, but the largest Syrian cities are included in its military map under the pretext of combating terrorism and preserving the territorial integrity of Syria.

“It is necessary for the world to realize that satisfying Turkey at the expense of the Syrian people will only have a temporary benefit for the countries concerned, and it will birth irreversible losses, damages and mistakes,” she added.

Ahmed also spoke about resentment among Syrians displaced by Turkey from their homes in Daraa, Ghouta, Damascus, Hama, Homs and Idlib and resettled them in Afrin.

“They are against Turkish policies and are now refusing to stay in homes that do not belong to them,” said Ahmed about the feelings of those uprooted by Turkey and forced to relocate to settlement projects set up by Ankara.

Speaking about several messages sent by the SDC to the Syrian regime, Ahmed said: “There is nothing new in the positions of the Damascus government.”

Ahmed pointed out that Damascus can show responsibility in deterring Turkish aggression and protecting the country’s borders.

“We hope that there will be an understanding about the border protection mechanism, especially that Russian and regime forces are present on contact points, along the borders in Kobani, Manbij, Al-Arima and Tal Rifaat in the Aleppo countryside,” added Ahmed.

“Certainly, our SDF forces have the necessary measures to confront the Turkish aggression and its occupation project, and our people are different from what they were in the past, so the battle will not go as they expect, and it will not resemble the previous battles,” warned Ahmed.

However, Ahmed noted that such a war will also cause great damage to the entire international community.

“We do not seek war; Rather, we seek to preserve the stability of our regions, which have turned into safe and secure areas for all Syrians.”

Ahmed pointed out that about 5 million Syrians live in Rojava areas.



Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation
TT

Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation

Dr. Mehmood Khan, CEO of the Hevolution Foundation, the largest philanthropy organization funding aging medicine in the world, expressed that receiving Saudi citizenship will boost his scientific and practical capabilities.
He said this new status will help him advance his research, especially in addressing aging.
This comes as part of a recent royal decree granting Saudi citizenship to several notable scholars, doctors, researchers, and innovators.
“Our Chairman, his Royal Highness (Crown Prince Mohammed bin Salman), has very high expectations of our work and the impact we need to do; We were created in part because of his vision,” Khan told Asharq Al-Awsat.
“Living up to the expectations and challenges we get faced with is itself exciting, but it is challenging,” revealed Khan, affirming that Hevolution’s team is “up to that task.”
Khan, who has experience in both corporate and medical fields, told Asharq Al-Awsat that his work across academic, public, and private sectors has been a continuous learning process, with each area enhancing the others.
According to the CEO, these industries are interconnected, and combining their strengths often leads to the best solutions.
This insight inspired the Hevolution initiative, which brings together the scientific community, NGOs, pharmaceutical companies, policymakers, academia, biotech firms, CEOs, and others to promote healthy aging.
Khan highlighted the value of integrating insights from different sectors.
Academia provides detailed research, the public sector offers insights on population health and regulations, and the corporate world brings innovation and efficiency, explained Khan, adding that by merging these perspectives, the world can tackle complex health challenges more effectively.
“We’ve been working through, and are now investing, funding and partnering with over 200 scientists around the world, and over 150 different university labs,” said Khan.
Hevolution uses this integrated approach to advance healthy aging.
This initiative embodies my passion for addressing major challenges and offers a significant opportunity to make a global impact.
Khan talked about the first $400 million commitment Hevolution made in the last 23 months, calling it “unprecedented.”
“There has never been a non-profit organization in the world that has gone from not existing to now becoming the largest philanthropy funding aging biology and medicine in the world,” affirmed Khan.
Khan stressed that work at Hevolution not only pushes scientific boundaries but also promotes cross-sector collaboration to improve global health outcomes.
Since Khan’s early days in medical school, he’s been deeply interested in nutrition and population health, which was an unconventional focus back then. This journey set the foundation for his later work in community health.
Khan’s time as an endocrinology faculty member at the Mayo Clinic was crucial. He led programs on diabetes, endocrine diseases, metabolism, and nutrition, which strengthened his expertise in designing disease prevention systems.
In the private sector, Khan took on a key role at Takeda Pharmaceutical as the global head of R&D, which shaped his approach to innovative healthcare solutions.
At PepsiCo, as Chief Scientific Officer, he learned crucial principles of scale, impact, transformation, and tackling global challenges.
As CEO of Hevolution, Khan uses all his professional experience to advance the foundation’s mission of developing health sciences to address age-related diseases.
Khan serves on the boards of Reckitt Benckiser and the Saudi Research, Development, and Innovation Authority (RDIA).
He is the CEO of Life Biosciences, a member of Saudi Arabia’s biotechnology strategy committee, and the chair of the advanced technology visiting committee at the US National Institute of Standards and Technology (NIST).
Khan told Asharq Al-Awsat that he feels honored to have recently become a Saudi citizen by royal decree, while also holding dual US and UK citizenship. This helps him lead Hevolution effectively and work closely with international partners.
Khan commented on his recent Saudi citizenship, saying that in addition to feeling honored to receive Saudi citizenship by royal decree, alongside other distinguished individuals, this recognition is a great privilege.
Being a Saudi citizen, as per Khan, is a significant milestone and acknowledges the progress in his work in aging science and global health. It also strengthens Khan’s commitment to the work at Hevolution.
Khan noted that this new status enhances his ability to build relationships and collaborate within the Kingdom and internationally. It offers a deeper connection with the local community and better opportunities to engage with policymakers and leaders.
He also said that this recognition boosts Hevolution’s global presence and credibility, making the foundation’s collaborations with international scientists and business leaders stronger. It positions Hevolution as a key player in addressing age-related diseases.
Khan emphasized that this honor reflects the hard work and innovation of Hevolution’s entire team.
The CEO said that it was collective efforts that have made this achievement possible.
Khan also said he is excited to engage more deeply with the scientific and medical community in the Kingdom, adding that his new citizenship helps him contribute to Vision 2030 and the national biotechnology strategy, promoting innovation and attracting top global talent.